| The role of peroxiredoxins in cancer A Nicolussi, S D'inzeo, C Capalbo, G Giannini, A Coppa Molecular and clinical oncology 6 (2), 139-153, 2017 | 195 | 2017 |
| Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma A Po, M Silvano, E Miele, C Capalbo, A Eramo, V Salvati, M Todaro, ... Oncogene 36 (32), 4641-4652, 2017 | 111 | 2017 |
| Next-generation sequencing: recent applications to the analysis of colorectal cancer F Del Vecchio, V Mastroiaco, A Di Marco, C Compagnoni, D Capece, ... Journal of translational medicine 15, 1-19, 2017 | 106 | 2017 |
| PCAF ubiquitin ligase activity inhibits Hedgehog/Gli1 signaling in p53-dependent response to genotoxic stress D Mazza, P Infante, V Colicchia, A Greco, R Alfonsi, M Siler, L Antonucci, ... Cell Death & Differentiation 20 (12), 1688-1697, 2013 | 102 | 2013 |
| PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma V Colicchia, M Petroni, G Guarguaglini, F Sardina, M Sahún-Roncero, ... Oncogene 36 (33), 4682-4691, 2017 | 101 | 2017 |
| Cancer secretome and inflammation: the bright and the dark sides of NF-κB D Capece, D Verzella, A Tessitore, E Alesse, C Capalbo, F Zazzeroni Seminars in cell & developmental biology 78, 51-61, 2018 | 97 | 2018 |
| microRNA‐17‐92 cluster is a direct Nanog target and controls neural stem cell through Trp53inp1 N Garg, A Po, E Miele, AF Campese, F Begalli, M Silvano, P Infante, ... The EMBO journal 32 (21), 2819-2832, 2013 | 77 | 2013 |
| Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma S Coni, AB Mancuso, L Di Magno, G Sdruscia, S Manni, SM Serrao, ... Scientific reports 7 (1), 44079, 2017 | 69 | 2017 |
| Characterization of the cancer spectrum in men with germline BRCA1 and BRCA2 pathogenic variants: results from the consortium of investigators of modifiers of BRCA1/2 (CIMBA) V Silvestri, G Leslie, DR Barnes, BA Agnarsson, K Aittomäki, E Alducci, ... JAMA oncology 6 (8), 1218-1230, 2020 | 65 | 2020 |
| Itch/β-arrestin2-dependent non-proteolytic ubiquitylation of SuFu controls Hedgehog signalling and medulloblastoma tumorigenesis P Infante, R Faedda, F Bernardi, F Bufalieri, L Lospinoso Severini, ... Nature communications 9 (1), 976, 2018 | 64 | 2018 |
| The exponential phase of the Covid-19 pandemic in central Italy: An integrated care pathway C Capalbo, A Aceti, M Simmaco, R Bonfini, M Rocco, A Ricci, C Napoli, ... International Journal of Environmental Research and Public Health 17 (11), 3792, 2020 | 59 | 2020 |
| Phenformin inhibits hedgehog-dependent tumor growth through a complex I-independent redox/corepressor module L Di Magno, S Manni, F Di Pastena, S Coni, A Macone, S Cairoli, ... Cell reports 30 (6), 1735-1752. e7, 2020 | 59 | 2020 |
| Predictive biomarkers for checkpoint inhibitor-based immunotherapy: the galectin-3 signature in NSCLCs C Capalbo, G Scafetta, M Filetti, P Marchetti, A Bartolazzi International journal of molecular sciences 20 (7), 1607, 2019 | 57 | 2019 |
| Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy P Rizzolo, V Zelli, V Silvestri, V Valentini, I Zanna, S Bianchi, G Masala, ... International Journal of Cancer 145 (2), 390-400, 2019 | 54 | 2019 |
| MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumors M Petroni, F Sardina, P Infante, A Bartolazzi, E Locatelli, F Fabretti, ... Cell death & disease 9 (9), 895, 2018 | 52 | 2018 |
| NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest G Diluvio, F Del Gaudio, MV Giuli, G Franciosa, E Giuliani, R Palermo, ... Oncogenesis 7 (5), 42, 2018 | 50 | 2018 |
| ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of βTrCP F Bufalieri, P Infante, F Bernardi, M Caimano, P Romania, M Moretti, ... Nature communications 10 (1), 3304, 2019 | 46 | 2019 |
| HER2-positive male breast cancer: an update L Ottini, C Capalbo, P Rizzolo, V Silvestri, G Bronte, S Rizzo, A Russo Breast Cancer: targets and therapy, 45-58, 2010 | 46 | 2010 |
| High-throughput microRNA profiling of pediatric high-grade gliomas E Miele, FR Buttarelli, A Arcella, F Begalli, N Garg, M Silvano, A Po, ... Neuro-oncology 16 (2), 228-240, 2014 | 42 | 2014 |
| BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models C Capalbo, E Ricevuto, A Vestri, E Ristori, T Sidoni, O Buffone, B Adamo, ... Annals of Oncology 17 (suppl 7), vii34, 2006 | 40 | 2006 |
